en
Pharmaceuticals
A C D E F G H I L M N P R S T V X Z
Elidel (Pimecrolimus)
Topical calcineurin inhibitor
Elidel is a registered trademark
Enablex (darifenacin)
Muscarinic M3 selective receptor antagonist
Enablex is a registered trademark
Estalis (Norethindrone Acetate and Estradiol-17β)
Transdermal Therapeutic Systems
Estalis is a registered trademark
Estalis-Sequi (Estradiol-17β and Norethindrone Acetate + Estradiol-17β)
Progestin-Estrogen
Estalis-Sequi is a registered trademark
Please note that this product has been discontinued by Novartis.
Estracomb (Estradiol-17β + Norethindrone Acetate and Estradiol-17β)
Estrogen-Progestin
Estracomb is a registered trademark
Please note that this product has been discontinued by Novartis.
Estraderm (Estradiol-17β)
Estrogen
Estraderm is a registered trademark
Estradot (Estradiol-17β)
Estrogen
Estradot is a registered trademark
Exelon (Rivastigmine Hydrogen Tartrate)
Cholinesterase Inhibitor
Exelon is a registered trademark
Exelon Patch (Rivastigmine Transdermal Patch)
Cholinesterase inhibitor
Exelon Patch is a registered trademark
Exjade (Deferasirox)
Iron Chelating Agent
Important information for healthcare professionals
Exjade is a registered trademark
Research
Novartis is one of the industry’s biggest investors in research.
ABOUT NOVARTIS
On March 7th, 1996 Sandoz and Ciba-Geigy, the two Swiss-based chemical/life sciences giants, became Novartis
Sandoz
Sandoz is one of the leaders in the development, manufacturing and distribution of generic pharmaceutical products.